Network Pharmacology Analyses of the Pharmacological Targets and Therapeutic Mechanisms of Salvianolic Acid A in Myocardial Infarction

Figure 8

Verification of the effects and therapeutic targets of salvianolic acid A in myocardial infarction. (a) The proliferation of H9C2 cells administrated with normoxia (control), oxygen‐glucose deprivation/reoxygenation (OGD/R) (model), and salvianolic acid A pretreatment. (b–k) Reverse transcription-quantitative PCR of SRC, CTNNB1, PIK3CA, AKT1, RELA, EGFR, FYN, ITGB1, MAPK8, and NFKB1 expressions in H9C2 cells administrated with normoxia (control), OGD/R (model), and salvianolic acid A pretreatment. ; ; .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)